Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study

PURPOSE: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with ulcerative colitis (UC) are extremely limited, especially in the Asian population. We compared clinically important outcomes [colectomy, UC-related emergency room (ER) visits, UC-related hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Minkyung, Jung, Yoon Suk, Cheon, Jae Hee, Park, Sohee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938779/
https://www.ncbi.nlm.nih.gov/pubmed/31887799
http://dx.doi.org/10.3349/ymj.2020.61.1.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938779/
https://www.ncbi.nlm.nih.gov/pubmed/31887799
http://dx.doi.org/10.3349/ymj.2020.61.1.48

Ejemplares similares